nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP3A5—Irinotecan—colon cancer	0.157	0.384	CbGbCtD
Granisetron—CYP3A5—Vincristine—colon cancer	0.137	0.336	CbGbCtD
Granisetron—HTR3A—myenteric nerve plexus—colon cancer	0.0625	0.622	CbGeAlD
Granisetron—CYP3A4—Irinotecan—colon cancer	0.0613	0.15	CbGbCtD
Granisetron—CYP3A4—Vincristine—colon cancer	0.0535	0.131	CbGbCtD
Granisetron—HTR3A—digestive system—colon cancer	0.00473	0.0471	CbGeAlD
Granisetron—CYP1A1—epithelium—colon cancer	0.00317	0.0315	CbGeAlD
Granisetron—CYP1A1—renal system—colon cancer	0.00294	0.0292	CbGeAlD
Granisetron—CYP3A5—renal system—colon cancer	0.00287	0.0286	CbGeAlD
Granisetron—CYP1A1—digestive system—colon cancer	0.00241	0.024	CbGeAlD
Granisetron—CYP3A5—digestive system—colon cancer	0.00236	0.0234	CbGeAlD
Granisetron—CYP3A4—renal system—colon cancer	0.00215	0.0214	CbGeAlD
Granisetron—Hyponatraemia—Capecitabine—colon cancer	0.00214	0.00436	CcSEcCtD
Granisetron—Melaena—Methotrexate—colon cancer	0.00213	0.00435	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00213	0.00434	CcSEcCtD
Granisetron—CYP1A1—vagina—colon cancer	0.00213	0.0212	CbGeAlD
Granisetron—CYP2D6—renal system—colon cancer	0.00212	0.0211	CbGeAlD
Granisetron—Visual impairment—Irinotecan—colon cancer	0.00212	0.00432	CcSEcCtD
Granisetron—Rhinitis—Fluorouracil—colon cancer	0.00211	0.00431	CcSEcCtD
Granisetron—Migraine—Capecitabine—colon cancer	0.00209	0.00427	CcSEcCtD
Granisetron—CYP3A5—vagina—colon cancer	0.00208	0.0207	CbGeAlD
Granisetron—Angiopathy—Vincristine—colon cancer	0.00205	0.00418	CcSEcCtD
Granisetron—Flushing—Irinotecan—colon cancer	0.00204	0.00416	CcSEcCtD
Granisetron—Alopecia—Vincristine—colon cancer	0.002	0.00407	CcSEcCtD
Granisetron—Angiopathy—Irinotecan—colon cancer	0.002	0.00407	CcSEcCtD
Granisetron—Coma—Methotrexate—colon cancer	0.00199	0.00407	CcSEcCtD
Granisetron—Chills—Irinotecan—colon cancer	0.00197	0.00402	CcSEcCtD
Granisetron—Arrhythmia—Irinotecan—colon cancer	0.00196	0.00401	CcSEcCtD
Granisetron—Liver function test abnormal—Capecitabine—colon cancer	0.00196	0.00401	CcSEcCtD
Granisetron—Alopecia—Irinotecan—colon cancer	0.00194	0.00396	CcSEcCtD
Granisetron—Orthostatic hypotension—Capecitabine—colon cancer	0.00194	0.00396	CcSEcCtD
Granisetron—Hypokalaemia—Capecitabine—colon cancer	0.00194	0.00395	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00192	0.00391	CcSEcCtD
Granisetron—Flatulence—Irinotecan—colon cancer	0.00189	0.00385	CcSEcCtD
Granisetron—Arrhythmia—Fluorouracil—colon cancer	0.00188	0.00384	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00188	0.00383	CcSEcCtD
Granisetron—Alopecia—Fluorouracil—colon cancer	0.00186	0.0038	CcSEcCtD
Granisetron—Abdominal distension—Capecitabine—colon cancer	0.00185	0.00378	CcSEcCtD
Granisetron—Anaemia—Vincristine—colon cancer	0.00182	0.00371	CcSEcCtD
Granisetron—Agitation—Vincristine—colon cancer	0.00181	0.00368	CcSEcCtD
Granisetron—Photosensitivity—Methotrexate—colon cancer	0.0018	0.00368	CcSEcCtD
Granisetron—CYP1A1—liver—colon cancer	0.00179	0.0179	CbGeAlD
Granisetron—Angina pectoris—Capecitabine—colon cancer	0.00179	0.00365	CcSEcCtD
Granisetron—Ill-defined disorder—Irinotecan—colon cancer	0.00178	0.00362	CcSEcCtD
Granisetron—Anaemia—Irinotecan—colon cancer	0.00177	0.00361	CcSEcCtD
Granisetron—CYP3A4—digestive system—colon cancer	0.00177	0.0176	CbGeAlD
Granisetron—Vertigo—Vincristine—colon cancer	0.00177	0.0036	CcSEcCtD
Granisetron—Leukopenia—Vincristine—colon cancer	0.00176	0.00359	CcSEcCtD
Granisetron—CYP3A5—liver—colon cancer	0.00175	0.0175	CbGeAlD
Granisetron—CYP2D6—digestive system—colon cancer	0.00174	0.0173	CbGeAlD
Granisetron—Malaise—Irinotecan—colon cancer	0.00173	0.00352	CcSEcCtD
Granisetron—Vertigo—Irinotecan—colon cancer	0.00172	0.00351	CcSEcCtD
Granisetron—Dysuria—Capecitabine—colon cancer	0.00172	0.00351	CcSEcCtD
Granisetron—Syncope—Irinotecan—colon cancer	0.00172	0.0035	CcSEcCtD
Granisetron—Leukopenia—Irinotecan—colon cancer	0.00171	0.0035	CcSEcCtD
Granisetron—Hypertension—Vincristine—colon cancer	0.0017	0.00346	CcSEcCtD
Granisetron—Anaemia—Fluorouracil—colon cancer	0.00169	0.00346	CcSEcCtD
Granisetron—Loss of consciousness—Irinotecan—colon cancer	0.00168	0.00343	CcSEcCtD
Granisetron—Photosensitivity reaction—Capecitabine—colon cancer	0.00168	0.00342	CcSEcCtD
Granisetron—Cough—Irinotecan—colon cancer	0.00167	0.00341	CcSEcCtD
Granisetron—Hypertension—Irinotecan—colon cancer	0.00165	0.00337	CcSEcCtD
Granisetron—Leukopenia—Fluorouracil—colon cancer	0.00164	0.00335	CcSEcCtD
Granisetron—Discomfort—Irinotecan—colon cancer	0.00161	0.00328	CcSEcCtD
Granisetron—Oedema—Vincristine—colon cancer	0.0016	0.00327	CcSEcCtD
Granisetron—Anaphylactic shock—Vincristine—colon cancer	0.0016	0.00327	CcSEcCtD
Granisetron—Jaundice—Capecitabine—colon cancer	0.0016	0.00326	CcSEcCtD
Granisetron—Infection—Vincristine—colon cancer	0.00159	0.00325	CcSEcCtD
Granisetron—Urinary tract infection—Capecitabine—colon cancer	0.00159	0.00325	CcSEcCtD
Granisetron—Nervous system disorder—Vincristine—colon cancer	0.00157	0.00321	CcSEcCtD
Granisetron—Thrombocytopenia—Vincristine—colon cancer	0.00157	0.0032	CcSEcCtD
Granisetron—Oedema—Irinotecan—colon cancer	0.00156	0.00319	CcSEcCtD
Granisetron—Anaphylactic shock—Irinotecan—colon cancer	0.00156	0.00319	CcSEcCtD
Granisetron—Chest pain—Fluorouracil—colon cancer	0.00156	0.00318	CcSEcCtD
Granisetron—Infection—Irinotecan—colon cancer	0.00155	0.00317	CcSEcCtD
Granisetron—Hyperhidrosis—Vincristine—colon cancer	0.00155	0.00316	CcSEcCtD
Granisetron—Hepatobiliary disease—Capecitabine—colon cancer	0.00155	0.00316	CcSEcCtD
Granisetron—Epistaxis—Capecitabine—colon cancer	0.00155	0.00315	CcSEcCtD
Granisetron—Discomfort—Fluorouracil—colon cancer	0.00154	0.00315	CcSEcCtD
Granisetron—Shock—Irinotecan—colon cancer	0.00154	0.00314	CcSEcCtD
Granisetron—Nervous system disorder—Irinotecan—colon cancer	0.00153	0.00313	CcSEcCtD
Granisetron—Thrombocytopenia—Irinotecan—colon cancer	0.00153	0.00312	CcSEcCtD
Granisetron—Hyperhidrosis—Irinotecan—colon cancer	0.00151	0.00308	CcSEcCtD
Granisetron—Hypotension—Vincristine—colon cancer	0.0015	0.00306	CcSEcCtD
Granisetron—Bradycardia—Capecitabine—colon cancer	0.0015	0.00306	CcSEcCtD
Granisetron—Anaphylactic shock—Fluorouracil—colon cancer	0.0015	0.00305	CcSEcCtD
Granisetron—Oedema—Fluorouracil—colon cancer	0.0015	0.00305	CcSEcCtD
Granisetron—Infection—Fluorouracil—colon cancer	0.00149	0.00303	CcSEcCtD
Granisetron—Rhinitis—Capecitabine—colon cancer	0.00148	0.00301	CcSEcCtD
Granisetron—Nervous system disorder—Fluorouracil—colon cancer	0.00147	0.00299	CcSEcCtD
Granisetron—Thrombocytopenia—Fluorouracil—colon cancer	0.00147	0.00299	CcSEcCtD
Granisetron—Liver function test abnormal—Methotrexate—colon cancer	0.00146	0.00298	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Vincristine—colon cancer	0.00146	0.00298	CcSEcCtD
Granisetron—Tachycardia—Fluorouracil—colon cancer	0.00146	0.00298	CcSEcCtD
Granisetron—Hypotension—Irinotecan—colon cancer	0.00146	0.00298	CcSEcCtD
Granisetron—Insomnia—Vincristine—colon cancer	0.00145	0.00296	CcSEcCtD
Granisetron—Connective tissue disorder—Capecitabine—colon cancer	0.00145	0.00295	CcSEcCtD
Granisetron—Paraesthesia—Vincristine—colon cancer	0.00144	0.00294	CcSEcCtD
Granisetron—Visual impairment—Capecitabine—colon cancer	0.00142	0.00289	CcSEcCtD
Granisetron—Insomnia—Irinotecan—colon cancer	0.00141	0.00288	CcSEcCtD
Granisetron—Paraesthesia—Irinotecan—colon cancer	0.0014	0.00286	CcSEcCtD
Granisetron—Hypotension—Fluorouracil—colon cancer	0.0014	0.00285	CcSEcCtD
Granisetron—Decreased appetite—Vincristine—colon cancer	0.00139	0.00284	CcSEcCtD
Granisetron—Dyspnoea—Irinotecan—colon cancer	0.00139	0.00284	CcSEcCtD
Granisetron—Somnolence—Irinotecan—colon cancer	0.00139	0.00283	CcSEcCtD
Granisetron—Gastrointestinal disorder—Vincristine—colon cancer	0.00139	0.00283	CcSEcCtD
Granisetron—CYP1A1—lymph node—colon cancer	0.00138	0.0137	CbGeAlD
Granisetron—Dyspepsia—Irinotecan—colon cancer	0.00138	0.00281	CcSEcCtD
Granisetron—Pain—Vincristine—colon cancer	0.00137	0.0028	CcSEcCtD
Granisetron—Constipation—Vincristine—colon cancer	0.00137	0.0028	CcSEcCtD
Granisetron—Flushing—Capecitabine—colon cancer	0.00137	0.00279	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00136	0.00278	CcSEcCtD
Granisetron—Decreased appetite—Irinotecan—colon cancer	0.00136	0.00277	CcSEcCtD
Granisetron—Eosinophilia—Methotrexate—colon cancer	0.00136	0.00276	CcSEcCtD
Granisetron—Insomnia—Fluorouracil—colon cancer	0.00135	0.00276	CcSEcCtD
Granisetron—Gastrointestinal disorder—Irinotecan—colon cancer	0.00135	0.00275	CcSEcCtD
Granisetron—Paraesthesia—Fluorouracil—colon cancer	0.00134	0.00274	CcSEcCtD
Granisetron—Pain—Irinotecan—colon cancer	0.00134	0.00273	CcSEcCtD
Granisetron—Constipation—Irinotecan—colon cancer	0.00134	0.00273	CcSEcCtD
Granisetron—Angiopathy—Capecitabine—colon cancer	0.00134	0.00272	CcSEcCtD
Granisetron—Dyspnoea—Fluorouracil—colon cancer	0.00133	0.00272	CcSEcCtD
Granisetron—Somnolence—Fluorouracil—colon cancer	0.00133	0.00271	CcSEcCtD
Granisetron—Chills—Capecitabine—colon cancer	0.00132	0.00269	CcSEcCtD
Granisetron—Dyspepsia—Fluorouracil—colon cancer	0.00132	0.00269	CcSEcCtD
Granisetron—CYP3A4—liver—colon cancer	0.00132	0.0131	CbGeAlD
Granisetron—Arrhythmia—Capecitabine—colon cancer	0.00131	0.00268	CcSEcCtD
Granisetron—Gastrointestinal pain—Vincristine—colon cancer	0.00131	0.00268	CcSEcCtD
Granisetron—Decreased appetite—Fluorouracil—colon cancer	0.0013	0.00265	CcSEcCtD
Granisetron—Alopecia—Capecitabine—colon cancer	0.0013	0.00265	CcSEcCtD
Granisetron—CYP2D6—liver—colon cancer	0.0013	0.0129	CbGeAlD
Granisetron—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00129	0.00264	CcSEcCtD
Granisetron—Feeling abnormal—Irinotecan—colon cancer	0.00129	0.00263	CcSEcCtD
Granisetron—Malnutrition—Capecitabine—colon cancer	0.00128	0.00261	CcSEcCtD
Granisetron—Dysuria—Methotrexate—colon cancer	0.00128	0.00261	CcSEcCtD
Granisetron—Pain—Fluorouracil—colon cancer	0.00128	0.00261	CcSEcCtD
Granisetron—Gastrointestinal pain—Irinotecan—colon cancer	0.00128	0.00261	CcSEcCtD
Granisetron—Abdominal pain—Vincristine—colon cancer	0.00127	0.00259	CcSEcCtD
Granisetron—Body temperature increased—Vincristine—colon cancer	0.00127	0.00259	CcSEcCtD
Granisetron—Flatulence—Capecitabine—colon cancer	0.00126	0.00258	CcSEcCtD
Granisetron—Dysgeusia—Capecitabine—colon cancer	0.00125	0.00256	CcSEcCtD
Granisetron—Photosensitivity reaction—Methotrexate—colon cancer	0.00125	0.00255	CcSEcCtD
Granisetron—Abdominal pain—Irinotecan—colon cancer	0.00124	0.00252	CcSEcCtD
Granisetron—Body temperature increased—Irinotecan—colon cancer	0.00124	0.00252	CcSEcCtD
Granisetron—Feeling abnormal—Fluorouracil—colon cancer	0.00123	0.00252	CcSEcCtD
Granisetron—Tremor—Capecitabine—colon cancer	0.0012	0.00245	CcSEcCtD
Granisetron—Ill-defined disorder—Capecitabine—colon cancer	0.00119	0.00242	CcSEcCtD
Granisetron—Urticaria—Fluorouracil—colon cancer	0.00119	0.00242	CcSEcCtD
Granisetron—Anaemia—Capecitabine—colon cancer	0.00118	0.00242	CcSEcCtD
Granisetron—Body temperature increased—Fluorouracil—colon cancer	0.00118	0.00241	CcSEcCtD
Granisetron—Hypersensitivity—Vincristine—colon cancer	0.00118	0.00241	CcSEcCtD
Granisetron—Sweating—Methotrexate—colon cancer	0.00117	0.00239	CcSEcCtD
Granisetron—Malaise—Capecitabine—colon cancer	0.00116	0.00236	CcSEcCtD
Granisetron—Hepatobiliary disease—Methotrexate—colon cancer	0.00115	0.00235	CcSEcCtD
Granisetron—Epistaxis—Methotrexate—colon cancer	0.00115	0.00235	CcSEcCtD
Granisetron—Vertigo—Capecitabine—colon cancer	0.00115	0.00235	CcSEcCtD
Granisetron—Hypersensitivity—Irinotecan—colon cancer	0.00115	0.00235	CcSEcCtD
Granisetron—Asthenia—Vincristine—colon cancer	0.00115	0.00235	CcSEcCtD
Granisetron—Syncope—Capecitabine—colon cancer	0.00115	0.00234	CcSEcCtD
Granisetron—Leukopenia—Capecitabine—colon cancer	0.00115	0.00234	CcSEcCtD
Granisetron—Palpitations—Capecitabine—colon cancer	0.00113	0.00231	CcSEcCtD
Granisetron—Loss of consciousness—Capecitabine—colon cancer	0.00113	0.0023	CcSEcCtD
Granisetron—Asthenia—Irinotecan—colon cancer	0.00112	0.00229	CcSEcCtD
Granisetron—Cough—Capecitabine—colon cancer	0.00112	0.00228	CcSEcCtD
Granisetron—Hypertension—Capecitabine—colon cancer	0.00111	0.00226	CcSEcCtD
Granisetron—Hypersensitivity—Fluorouracil—colon cancer	0.0011	0.00225	CcSEcCtD
Granisetron—Diarrhoea—Vincristine—colon cancer	0.0011	0.00224	CcSEcCtD
Granisetron—Chest pain—Capecitabine—colon cancer	0.00109	0.00222	CcSEcCtD
Granisetron—Arthralgia—Capecitabine—colon cancer	0.00109	0.00222	CcSEcCtD
Granisetron—Anxiety—Capecitabine—colon cancer	0.00109	0.00222	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00108	0.00221	CcSEcCtD
Granisetron—Discomfort—Capecitabine—colon cancer	0.00108	0.0022	CcSEcCtD
Granisetron—Diarrhoea—Irinotecan—colon cancer	0.00107	0.00218	CcSEcCtD
Granisetron—Dry mouth—Capecitabine—colon cancer	0.00107	0.00218	CcSEcCtD
Granisetron—Dizziness—Vincristine—colon cancer	0.00106	0.00216	CcSEcCtD
Granisetron—Pruritus—Fluorouracil—colon cancer	0.00106	0.00216	CcSEcCtD
Granisetron—Visual impairment—Methotrexate—colon cancer	0.00106	0.00215	CcSEcCtD
Granisetron—Oedema—Capecitabine—colon cancer	0.00105	0.00213	CcSEcCtD
Granisetron—Infection—Capecitabine—colon cancer	0.00104	0.00212	CcSEcCtD
Granisetron—Dizziness—Irinotecan—colon cancer	0.00103	0.00211	CcSEcCtD
Granisetron—Shock—Capecitabine—colon cancer	0.00103	0.0021	CcSEcCtD
Granisetron—Nervous system disorder—Capecitabine—colon cancer	0.00103	0.00209	CcSEcCtD
Granisetron—Diarrhoea—Fluorouracil—colon cancer	0.00102	0.00209	CcSEcCtD
Granisetron—Thrombocytopenia—Capecitabine—colon cancer	0.00102	0.00209	CcSEcCtD
Granisetron—Tachycardia—Capecitabine—colon cancer	0.00102	0.00208	CcSEcCtD
Granisetron—Vomiting—Vincristine—colon cancer	0.00102	0.00208	CcSEcCtD
Granisetron—Skin disorder—Capecitabine—colon cancer	0.00102	0.00207	CcSEcCtD
Granisetron—Rash—Vincristine—colon cancer	0.00101	0.00206	CcSEcCtD
Granisetron—Hyperhidrosis—Capecitabine—colon cancer	0.00101	0.00206	CcSEcCtD
Granisetron—Dermatitis—Vincristine—colon cancer	0.00101	0.00206	CcSEcCtD
Granisetron—Headache—Vincristine—colon cancer	0.00101	0.00205	CcSEcCtD
Granisetron—Angiopathy—Methotrexate—colon cancer	0.000994	0.00203	CcSEcCtD
Granisetron—Vomiting—Irinotecan—colon cancer	0.000993	0.00203	CcSEcCtD
Granisetron—Dizziness—Fluorouracil—colon cancer	0.00099	0.00202	CcSEcCtD
Granisetron—Rash—Irinotecan—colon cancer	0.000985	0.00201	CcSEcCtD
Granisetron—Dermatitis—Irinotecan—colon cancer	0.000984	0.00201	CcSEcCtD
Granisetron—Chills—Methotrexate—colon cancer	0.000983	0.00201	CcSEcCtD
Granisetron—Headache—Irinotecan—colon cancer	0.000979	0.002	CcSEcCtD
Granisetron—Hypotension—Capecitabine—colon cancer	0.000977	0.00199	CcSEcCtD
Granisetron—Alopecia—Methotrexate—colon cancer	0.000968	0.00197	CcSEcCtD
Granisetron—Malnutrition—Methotrexate—colon cancer	0.000954	0.00195	CcSEcCtD
Granisetron—Nausea—Vincristine—colon cancer	0.000953	0.00194	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000953	0.00194	CcSEcCtD
Granisetron—Vomiting—Fluorouracil—colon cancer	0.000951	0.00194	CcSEcCtD
Granisetron—Insomnia—Capecitabine—colon cancer	0.000946	0.00193	CcSEcCtD
Granisetron—Rash—Fluorouracil—colon cancer	0.000943	0.00192	CcSEcCtD
Granisetron—Dermatitis—Fluorouracil—colon cancer	0.000943	0.00192	CcSEcCtD
Granisetron—Paraesthesia—Capecitabine—colon cancer	0.000939	0.00192	CcSEcCtD
Granisetron—Headache—Fluorouracil—colon cancer	0.000937	0.00191	CcSEcCtD
Granisetron—Dysgeusia—Methotrexate—colon cancer	0.000934	0.00191	CcSEcCtD
Granisetron—Dyspnoea—Capecitabine—colon cancer	0.000932	0.0019	CcSEcCtD
Granisetron—Nausea—Irinotecan—colon cancer	0.000928	0.00189	CcSEcCtD
Granisetron—Dyspepsia—Capecitabine—colon cancer	0.00092	0.00188	CcSEcCtD
Granisetron—Decreased appetite—Capecitabine—colon cancer	0.000909	0.00185	CcSEcCtD
Granisetron—Gastrointestinal disorder—Capecitabine—colon cancer	0.000903	0.00184	CcSEcCtD
Granisetron—Constipation—Capecitabine—colon cancer	0.000894	0.00182	CcSEcCtD
Granisetron—Pain—Capecitabine—colon cancer	0.000894	0.00182	CcSEcCtD
Granisetron—Nausea—Fluorouracil—colon cancer	0.000889	0.00181	CcSEcCtD
Granisetron—Ill-defined disorder—Methotrexate—colon cancer	0.000885	0.00181	CcSEcCtD
Granisetron—Anaemia—Methotrexate—colon cancer	0.000882	0.0018	CcSEcCtD
Granisetron—Feeling abnormal—Capecitabine—colon cancer	0.000862	0.00176	CcSEcCtD
Granisetron—Malaise—Methotrexate—colon cancer	0.00086	0.00175	CcSEcCtD
Granisetron—Vertigo—Methotrexate—colon cancer	0.000857	0.00175	CcSEcCtD
Granisetron—Gastrointestinal pain—Capecitabine—colon cancer	0.000855	0.00174	CcSEcCtD
Granisetron—Leukopenia—Methotrexate—colon cancer	0.000854	0.00174	CcSEcCtD
Granisetron—Cough—Methotrexate—colon cancer	0.000832	0.0017	CcSEcCtD
Granisetron—Urticaria—Capecitabine—colon cancer	0.000831	0.00169	CcSEcCtD
Granisetron—Abdominal pain—Capecitabine—colon cancer	0.000827	0.00169	CcSEcCtD
Granisetron—Body temperature increased—Capecitabine—colon cancer	0.000827	0.00169	CcSEcCtD
Granisetron—Arthralgia—Methotrexate—colon cancer	0.000812	0.00166	CcSEcCtD
Granisetron—Chest pain—Methotrexate—colon cancer	0.000812	0.00166	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000806	0.00164	CcSEcCtD
Granisetron—Discomfort—Methotrexate—colon cancer	0.000802	0.00164	CcSEcCtD
Granisetron—Anaphylactic shock—Methotrexate—colon cancer	0.000778	0.00159	CcSEcCtD
Granisetron—Infection—Methotrexate—colon cancer	0.000773	0.00158	CcSEcCtD
Granisetron—Hypersensitivity—Capecitabine—colon cancer	0.00077	0.00157	CcSEcCtD
Granisetron—Nervous system disorder—Methotrexate—colon cancer	0.000763	0.00156	CcSEcCtD
Granisetron—Thrombocytopenia—Methotrexate—colon cancer	0.000762	0.00155	CcSEcCtD
Granisetron—Skin disorder—Methotrexate—colon cancer	0.000756	0.00154	CcSEcCtD
Granisetron—Hyperhidrosis—Methotrexate—colon cancer	0.000753	0.00153	CcSEcCtD
Granisetron—Asthenia—Capecitabine—colon cancer	0.00075	0.00153	CcSEcCtD
Granisetron—Pruritus—Capecitabine—colon cancer	0.00074	0.00151	CcSEcCtD
Granisetron—Hypotension—Methotrexate—colon cancer	0.000727	0.00148	CcSEcCtD
Granisetron—Diarrhoea—Capecitabine—colon cancer	0.000715	0.00146	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000709	0.00145	CcSEcCtD
Granisetron—Insomnia—Methotrexate—colon cancer	0.000704	0.00144	CcSEcCtD
Granisetron—Paraesthesia—Methotrexate—colon cancer	0.000699	0.00143	CcSEcCtD
Granisetron—Dyspnoea—Methotrexate—colon cancer	0.000694	0.00142	CcSEcCtD
Granisetron—Somnolence—Methotrexate—colon cancer	0.000692	0.00141	CcSEcCtD
Granisetron—Dizziness—Capecitabine—colon cancer	0.000691	0.00141	CcSEcCtD
Granisetron—Dyspepsia—Methotrexate—colon cancer	0.000685	0.0014	CcSEcCtD
Granisetron—Decreased appetite—Methotrexate—colon cancer	0.000677	0.00138	CcSEcCtD
Granisetron—Gastrointestinal disorder—Methotrexate—colon cancer	0.000672	0.00137	CcSEcCtD
Granisetron—Pain—Methotrexate—colon cancer	0.000666	0.00136	CcSEcCtD
Granisetron—Vomiting—Capecitabine—colon cancer	0.000665	0.00136	CcSEcCtD
Granisetron—Rash—Capecitabine—colon cancer	0.000659	0.00134	CcSEcCtD
Granisetron—Dermatitis—Capecitabine—colon cancer	0.000659	0.00134	CcSEcCtD
Granisetron—Headache—Capecitabine—colon cancer	0.000655	0.00134	CcSEcCtD
Granisetron—Feeling abnormal—Methotrexate—colon cancer	0.000641	0.00131	CcSEcCtD
Granisetron—Gastrointestinal pain—Methotrexate—colon cancer	0.000637	0.0013	CcSEcCtD
Granisetron—Nausea—Capecitabine—colon cancer	0.000621	0.00127	CcSEcCtD
Granisetron—Urticaria—Methotrexate—colon cancer	0.000618	0.00126	CcSEcCtD
Granisetron—Abdominal pain—Methotrexate—colon cancer	0.000615	0.00126	CcSEcCtD
Granisetron—Body temperature increased—Methotrexate—colon cancer	0.000615	0.00126	CcSEcCtD
Granisetron—Hypersensitivity—Methotrexate—colon cancer	0.000574	0.00117	CcSEcCtD
Granisetron—Asthenia—Methotrexate—colon cancer	0.000559	0.00114	CcSEcCtD
Granisetron—Pruritus—Methotrexate—colon cancer	0.000551	0.00112	CcSEcCtD
Granisetron—Diarrhoea—Methotrexate—colon cancer	0.000533	0.00109	CcSEcCtD
Granisetron—Dizziness—Methotrexate—colon cancer	0.000515	0.00105	CcSEcCtD
Granisetron—Vomiting—Methotrexate—colon cancer	0.000495	0.00101	CcSEcCtD
Granisetron—Rash—Methotrexate—colon cancer	0.000491	0.001	CcSEcCtD
Granisetron—Dermatitis—Methotrexate—colon cancer	0.00049	0.001	CcSEcCtD
Granisetron—Headache—Methotrexate—colon cancer	0.000488	0.000995	CcSEcCtD
Granisetron—Nausea—Methotrexate—colon cancer	0.000462	0.000943	CcSEcCtD
